Contract 36F79719D0246

Merz Pharmaceuticals, Llc · Department Of Veterans Affairs · June 25, 2024

Fixed Price With Economic Price AdjustmentFull & Open CompetitionNAICS 325412

Merz Pharmaceuticals, Llc was awarded a federal contract by Department Of Veterans Affairs on June 25, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 7 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 13, 2026. If all options are exercised, the contract could reach $95.73 million.

Potential value
$95.73M
if all options exercised
Modifications
7
Latest March 13, 2026

Contract details

PIID
36F79719D0246
Award type
Pricing
Fixed Price With Economic Price Adjustment
Set-aside
No Set Aside Used.
Competition
Full And Open Competition
NAICS
325412 · Pharmaceutical Preparation Manufacturing
Product / service
Drugs And Biologicals
First action
June 25, 2024
Latest action
March 13, 2026

Description

42-2A NDC CHANGE FOR 1 NDC (AMPYRA)

Modification timeline

  • March 13, 2026
    Mod P00033 · Supplemental Agreement For Work Within Scope
    $0
  • December 22, 2025
    Mod P00032 · Supplemental Agreement For Work Within Scope
    TEMPORARY CONTRACT EXTENSION THROUGH 09-27-2027
    $0
  • December 15, 2025
    Mod P00031 · Supplemental Agreement For Work Within Scope
    TEMPORARY PRICE REDUCTIONS FOR 3 NDCS (VA ONLY)
    $0
  • December 15, 2025
    Mod P00030 · Supplemental Agreement For Work Within Scope
    TEMPORARY PRICE REDUCTIONS FOR 3 NDCS
    $0
  • December 5, 2025
    Mod P00028 · Supplemental Agreement For Work Within Scope
    2026 PUBLIC LAW PRICING UPDATE
    $0
  • August 7, 2025
    Mod P00027 · Supplemental Agreement For Work Within Scope
    TEMPORARY CONTRACT EXTENSION 09-14-2025 TO 09-14-2026
    $0
  • September 5, 2024
    Mod P00024 · Supplemental Agreement For Work Within Scope
    65IB - PRODUCT ADDITION PERMANENT STAGE - 42-2A - TRANSFER FROM ACORDA THERAPEUTICS, INC.
    $0
  • June 25, 2024
    Mod P00023 · Supplemental Agreement For Work Within Scope
    65IB: TEMPORARY EXTENSION OF FSS CONTRACT 36F79719D0246
    $0

Similar contracts

RecipientAgencyDateObligated
Petnet Solutions, Inc.Department Of Veterans AffairsApril 1, 2026$387.4K
Eli Lilly And CompanyDepartment Of Veterans AffairsApril 1, 2026$0
Exelan Pharmaceuticals IncDepartment Of Veterans AffairsApril 1, 2026$0
Cardinal Health 414, LlcDepartment Of Veterans AffairsApril 1, 2026$122.9K
Guardian Pharmacy Of Indianapolis Nuclear, LlcDepartment Of Veterans AffairsApril 1, 2026$0
Jubilant Draximage IncDepartment Of Veterans AffairsApril 1, 2026$0

Top contractors in NAICS 325412

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Mckesson Corporation1,187$4.96B
2Merck Sharp & Dohme Llc26$894.71M
3Sanofi Vaccines Us Inc.57$702.38M
4Pfizer Inc169$541.15M
5Glaxosmithkline, Llc14$505.04M
6Phlow Corp.1$105.27M
7Exelan Pharmaceuticals Inc76$104.30M
8Seqirus USA Inc47$59.15M
9Emergent Biosolutions Canada Inc2$53.73M
10Mckesson Specialty Distribution Llc1$51.05M

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract 36F79719D0246?

Contract 36F79719D0246 is a federal contract awarded to Merz Pharmaceuticals, Llc by Department Of Veterans Affairs on June 25, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 7 times since the base award.

Who won contract 36F79719D0246?

Merz Pharmaceuticals, Llc won contract 36F79719D0246 from Department Of Veterans Affairs.

How much is contract 36F79719D0246 worth?

Contract 36F79719D0246 has obligated $0 to date but carries a potential ceiling of $95.73 million if fully funded and all options are exercised.